【Heng Rong Science】The Company Signs MOU with Yi-Da Medical Center for Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Center Establishment
Key facts
- 【Heng Rong Science】The Company Signs MOU with Yi-Da Medical Center for Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Center Establishment
- Heng Rong Science and Yi-Da Medical Center have signed an MOU to establish an AB-BNCT center, aiming to advance cancer treatment technology.
- Source: TWSE
- Date: Mon Jun 15 2026 09:00:00 GMT+0900 (Japan Standard Time)
Direct answer
Heng Rong Science and Yi-Da Medical Center have signed an MOU to establish an AB-BNCT center, aiming to advance cancer treatment technology.
- Citation
- 【Heng Rong Science】The Company Signs MOU with Yi-Da Medical Center for Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Center Establishment (Mon Jun 15 2026 09:00:00 GMT+0900 (Japan Standard Time)), TWSE
- Source
- TWSE
- Date
- Mon Jun 15 2026 09:00:00 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Heng Rong Science and Yi-Da Medical Center have signed an MOU to establish an AB-BNCT center, aiming to advance cancer treatment technology.
AI Analysis
Frequently Asked Questions
- Q: What is the purpose of the collaboration between Heng Rong Science and Yi-Da Medical Center?
- A: To advance the clinical application and market expansion of AB-BNCT technology.
- Q: What is Yi-Da Medical Center's contribution to AB-BNCT technology?
- A: As a leading institution in cancer care and academic research in southern Taiwan, it has a dedicated cancer treatment area and a multidisciplinary medical team.
- Q: What are Heng Rong Science's strengths in AB-BNCT technology?
- A: Capabilities in equipment integration, technology R&D, and clinical application promotion.
- Q: What impact does this collaboration have on Heng Rong Science?
- A: It contributes to the deepening of international layout and the development of AB-BNCT business.
- Q: What is the market potential of AB-BNCT technology?
- A: The expansion of potential markets is expected.